Skip to main contentSkip to main content
You have permission to edit this article.
Edit

Breast Cancer Survivors Can Safely Pause Longer-Term Meds During Pregnancy

  • Updated
  • 0
Breast Cancer Survivors Can Safely Pause Longer-Term Meds During Pregnancy

THURSDAY, Dec. 8, 2022 (HealthDay News) -- Pausing longer-term hormonal therapies to have a baby will not raise a breast cancer survivor's risk of her tumor recurring, a new clinical trial concludes.

Women whose cancer is fueled by female hormones such as estrogen often are treated with medications -- such as aromatase inhibitors or tamoxifen -- that suppress those hormones or block their function, in an effort to keep the cancer from coming back.

In a new study, women who suspended their hormone therapy to conceive a baby had about the same short-term rate of breast cancer recurrence as those who remained on the therapy, researchers said at a presentation held Thursday at the San Antonio Breast Cancer Symposium.

This clinical trial "provides important data to support young women with HR-positive early breast cancer who are interested in a pregnancy and taking a break from endocrine [hormonal] therapy to pursue one," said lead researcher Dr. Ann Partridge, vice chair of oncology at Dana-Farber Cancer Institute in Boston.

One expert applauded the new study and its findings.

"This trial is very exciting," said Dr. Marleen Meyers, a medical oncologist at NYU Langone Perlmutter Cancer Center in New York City. She wasn't involved in the study.

"One of the most devastating results for young women with breast cancer is the potential loss of fertility and ability to have biologic children," Meyers explained. And with hormonal therapy typically been prescribed for five to 10 years, "waiting to complete treatment makes the possibility of carry a child less realistic," she said.

"This study offers hope for some women with hormone receptor-positive breast cancer to be able to interrupt cancer treatment and still have good outcomes," Meyers said.

Breast cancer most commonly occurs in women past childbearing age, but about 5% of new diagnoses occur in women 40 or younger, researchers said in background notes.

Younger patients have to juggle their disease with treatment’s possible effects on their health and fertility, Partridge explained.

"Forty to 60 percent of patients who are diagnosed with breast cancer at age 40 or younger are concerned about their future fertility, especially if the disease occurs before they could decide whether to become a mother or not,” Partridge said in a meeting news release.

Previous studies have shown that pregnancy after cancer is feasible and safe, but many women are worried that breast cancer treatments might interfere with conception, the researchers explained. They’re also worried that pregnancy might increase their cancer risk.

Partridge's team hoped to settle these issues. Between December 2014 and December 2019, they recruited 518 breast cancer survivors age 42 or younger who wanted to become pregnant. Patients were enrolled in 116 medical centers from 20 countries around the world.

These women opted to pause their hormone therapy for about two years while they tried to conceive. Before this pause, the women had completed between 18 and 30 months of hormone therapy.

After a little more than three years, 44 participants had experienced a recurrence of breast cancer.

That three-year rate of recurrence, 8.9%, was similar to a 9.2% rate seen in a control group of breast cancer patients who continued their hormone therapy.

About 74% of the trial participants had at least one pregnancy, and about 64% had at least one live birth. Overall, 365 babies were born to these breast cancer survivors.

These rates of conception and childbirth are on par with or higher than rates seen in the general public, researchers said.

Once their families were complete, the women were strongly encouraged to resume hormone therapy. To date, about 3 out of 4 have started back with their meds.

"The strength of the study is that it is the first real evidence we have of safety in interrupting treatment for pregnancy, as well as the knowledge that the babies appear to be healthy," Meyers noted.

However, she added that longer follow-up data is needed. The researchers said they do plan to continue tracking these women for any long-term health problems.

"Pregnancy after breast cancer is a very personal decision for which, ideally, a woman should take into account not only her desire to carry a pregnancy, but her baseline fertility, prior and current treatment, and any fertility preservation strategy she may have pursued, as well as the underlying risk of cancer recurrence she faces," said co-researcher Dr. Olivia Pagani, a member of the Swiss Group for Clinical Cancer Research.

Findings presented at medical meetings are considered preliminary until published in a peer-reviewed journal.

More information

The American Cancer Society has more about hormone therapy for breast cancer.

SOURCES: Marleen Meyers, MD, medical oncologist, NYU Langone Perlmutter Cancer Center, New York City; San Antonio Breast Cancer Symposium, news release, Dec. 8, 2022

0 Comments
0
0
0
0
0

Originally published on consumer.healthday.com, part of the TownNews Content Exchange.

* I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy.

Related to this story

Most Popular

Japan and South Korea are defending their public health restrictions on travelers from China after Beijing stopped issuing new visas in both countries in apparent retaliation. Chinese embassies stopped issuing new visas for South Koreans and Japanese on Tuesday. It wasn’t clear whether China would expand the visa suspensions to other countries that have imposed stricter virus testing on passengers from China following its COVID-19 surge. According to South Korea’s Disease Control and Prevention Agency, about 17% of the 2,550 short-term travelers from China since Jan. 2 have tested positive.

China will not include Pfizer’s COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price, saying it was too expensive. The oral medicine Paxlovid developed by New York-based drugmaker Pfizer has been widely sought after in China since the country began phasing out its “zero-COVID” restrictions and infections started surging. China will include two other domestic COVID-19 drugs in the reimbursement list. Policymakers can leverage bulk purchases to lower prices in negotiations with pharmaceutical companies that, in turn, can net a steady source of revenue. A drug must be included on the reimbursement list to be covered by the national insurance scheme.

Nurses who went on strike this month at two major New York City hospitals have ratified the contracts that were hammered out to end the walkout. Their union, called the New York State Nurses Association, said Tuesday that 98% of nurses at Mount Sinai Hospital and Montefiore Medical Center voted  in favor of the contracts. They include raises totaling 19% over three years, commitments to hire more nurses and new provisions to enforce promised staffing levels. Mount Sinai President Dr. David Reich told hospital staff in a memo the contract “puts patients first.” Together, they employ over 7,000 union nurses.

FRIDAY, Jan. 20, 2023 (HealthDay News) -- From 2017-2018 to 2019-2020, there has been a decrease in opioid prescribing at discharge from the emergency department, according to a January data brief published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.

Officials say a 32—year-old mother in Massachusetts is expected to be charged in the killing of her two children and the injuring of her infant son. Authorities arrived at a house in Duxbury on Tuesday night after receiving reports of a woman jumping out of a window. They found her and the children unconscious with obvious signs of trauma. Plymouth District Attorney Timothy Cruz says the mother, Lindsay Clancy, remains hospitalized and will be arraigned on homicide charges after she is released. He says it appears the children were strangled. Police and firefighters responded to the home after getting a 911 call from a male resident who reported the woman jumped out the window.

Listen now and subscribe: Apple Podcasts | Google Podcasts | Spotify | Stitcher | RSS Feed | Omny Studio

Get up-to-the-minute news sent straight to your device.

Topics

News Alerts

Breaking News